Jasmine Pennic

Healthcare operations company UnityAI has launched a strategic partnership with national substance use disorder (SUD) treatment provider Spero Health to automate inbound patient intake and scheduling. Spero Health will deploy UnityAI’s PatientOps platform across its network of over 60 locations to eliminate long hold times, missed patient connections, and front-line friction during critical moments of treatment readiness.

Moffitt Cancer Center has announced the expansion of its hybrid virtual oncology care program with Reimagine Care, deploying the conversational AI-powered assistant Remi alongside a dedicated virtual clinical team. An initial implementation phase covering nearly 7,000 digital patient interactions demonstrated that 97% of patient encounters were independently resolved virtually without requiring escalation to Moffitt providers.

Global AI therapy platform The Path— previously known as Mental—has officially launched out of stealth with $14.3M in seed funding led by Prime Movers Lab. The company was co-founded by philanthropist Tony Robbins alongside Calm veterans Anson Whitmer (former head of data science and AI) and Tyler Sheaffer (former engineering lead).

Digital Twin Care Platform pioneer Twin Health has officially launched its proprietary GLP-1 Stewardship Model, establishing a clear clinical framework to reduce long-term patient dependence on high-cost weight loss medications. In a randomized clinical trial published in the New England Journal of Medicine Catalyst, 85% of Twin participants successfully discontinued GLP-1 therapies while losing two times more weight than the control group.

Headspace has published its 8th annual Workforce State of Mind report, revealing a pervasive “chronic strain” crisis characterized by an unrelenting accumulation of mental and cognitive pressure. According to the study, a staggering 92% of workers are actively experiencing mental or cognitive strain, with 37% reporting that this pressure has intensified over the past year.

Consumer health data platform b.well Connected Health has announced a strategic partnership with global health tech leader myTomorrows to automate and accelerate how patients are matched and enrolled into clinical trials.

Digital health and behavior change leader Noom has launched a $125 at-home Biomarkers Test Kit for its U.S. membership base, targeting comprehensive metabolic and cardiovascular tracking. Utilizing the Tasso+ device for painless blood collection, the kit tracks 17 clinically significant biomarkers, including gold-standard measures like HbA1c, ApoB, triglycerides, hs-CRP, and the genetic risk factor Lp(a).

GoodRx has officially launched GoodRx Companion, a new $14.99-per-month membership program designed to lower out-of-pocket consumer expenditures across everyday clinical touchpoints. Moving beyond transaction-focused pharmacy coupons, the subscription unifies free access to more than 200 common generic medications with hundreds more priced under $10 at nearly every domestic retail pharmacy.

Clinical AI leader Ambience Healthcare has announced a major expansion of its chart-aware intelligence across its enterprise inpatient platform, embedding deep chart reasoning into every phase of a hospital stay. Inpatient documentation relies heavily on non-conversational metrics; Ambience’s internal data shows that 70% of clinically important inpatient diagnoses have no signal in a traditional audio transcript.

Virtual women’s health pioneer Teal Health has announced a strategic research collaboration with the Washington University School of Medicine in St. Louis to expand cervical cancer screening access. Orchestrated through the SCORE Initiative at Siteman Cancer Center, the pilot study targets women who have fallen out of touch with the traditional healthcare system and routine preventative care.